Literature DB >> 2570360

N-methyl-D-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor location, characterization and desensitization.

K Fink1, M Göthert, G Molderings, E Schlicker.   

Abstract

Rat brain cortex slices and synaptosomes (in a few experiments also hippocampal synaptosomes) preincubated with 3H-noradrenaline, 3H-5-hydroxytryptamine, 3H-choline, 3H-glutamate or 3H-gamma-aminobutyric acid were used to investigate the 3H-transmitter release in response to exposure to N-methyl-D-aspartate (NMDA) and other excitatory amino acids. The slices and synaptosomes were superfused with Mg2+-free, otherwise physiologically composed salt solution. In cortical slices preincubated with 3H-noradrenaline, NMDA concentration-dependently stimulated 3H overflow, whereas no such effect occurred in slices preincubated with 3H-5-hydroxytryptamine, 3H-choline, 3H-glutamate or 3H-gamma-aminobutyric acid. In cortical slices preincubated with 3H-noradrenaline, the NMDA-evoked 3H overflow was abolished by tetrodotoxin, presence of Mg2+ 1.2 mmol/l or absence of Ca2+. 2-Amino-5-phosphonovaleric acid produced a parallel shift to the right of the NMDA concentration-response curve, whereas (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohept- 5,10-imine hydrogen maleate (MK-801) not only shifted the concentration-response curve to the right but also reduced the maximum effect of NMDA. Other excitatory amino acid receptor agonists also stimulated 3H overflow, yielding the following rank order of potency: NMDA greater than L-glutamate greater than L-aspartate. Kainate and, in particular, quisqualate exhibited only low potencies and/or intrinsic activities. Prolonged (25 min) exposure of 3H-NA-preincubated cortical slices to a high NMDA concentration produced a short-lasting peak of 3H overflow, followed by a second phase lasting as long as the compound was present; in this phase, 3H overflow was clearly less pronounced and gradually decreased with time.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570360     DOI: 10.1007/BF00167254

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system.

Authors:  A H Mulder; W B van den Berg; J C Stoof
Journal:  Brain Res       Date:  1975-12-05       Impact factor: 3.252

Review 2.  Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity.

Authors:  C W Cotman; D T Monaghan; A H Ganong
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

3.  Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.

Authors:  L D Snell; K M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1985-10       Impact factor: 4.030

4.  Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices.

Authors:  J Lehmann; B Scatton
Journal:  Brain Res       Date:  1982-12-02       Impact factor: 3.252

5.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.

Authors:  M L Mayer; G L Westbrook; P B Guthrie
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

6.  Inhibition of N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release by phencyclidine is dependent on potassium concentration.

Authors:  L D Snell; S M Jones; K M Johnson
Journal:  Neurosci Lett       Date:  1987-08-05       Impact factor: 3.046

7.  Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release.

Authors:  L D Snell; S J Yi; K M Johnson
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

8.  Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex.

Authors:  N L Harrison; M A Simmonds
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

9.  Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.

Authors:  S M Jones; L D Snell; K M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

10.  Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.

Authors:  L D Snell; K M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1986-09       Impact factor: 4.030

View more
  24 in total

1.  Ih channels as modulators of presynaptic terminal function: ZD7288 increases NMDA-evoked [3H]-noradrenaline release in rat neocortex slices.

Authors:  Maximilian Klar; Rainer Surges; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-13       Impact factor: 3.000

Review 2.  The putative molecular mechanism(s) responsible for the enhanced inositol phosphate synthesis by excitatory amino acids: an overview.

Authors:  M Récasens; J Guiramand; M Vignes
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

3.  Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.

Authors:  Nigar Yilmaz; Arif Demirdas; Mustafa Yilmaz; Recep Sutcu; Aynur Kirbas; Medine Cumhur Cure; Ibrahim Eren
Journal:  J Membr Biol       Date:  2011-07-14       Impact factor: 1.843

4.  Inhibition of N-methyl-D-aspartate (NMDA)- and L-glutamate-induced noradrenaline and acetylcholine release in the rat brain by ethanol.

Authors:  M Göthert; K Fink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

5.  Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases.

Authors:  Guendalina Olivero; Matteo Vergassola; Francesca Cisani; Cesare Usai; Anna Pittaluga
Journal:  Mol Neurobiol       Date:  2019-02-07       Impact factor: 5.590

6.  Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.

Authors:  F P Monnet; B R de Costa; W D Bowen
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

7.  NMDA and AMPA receptors evoke transmitter release from noradrenergic axon terminals in the rat spinal cord.

Authors:  E Sundström; L Holmberg; F Souverbie
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

8.  N-methyl-D-aspartate (NMDA)-stimulated noradrenaline (NA) release in rat brain cortex is modulated by presynaptic H3-receptors.

Authors:  K Fink; E Schlicker; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

9.  Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.

Authors:  K Fink; R Schultheiss; M Göthert
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

10.  Preferential location of N-methyl-D-aspartate (NMDA) receptors on postsynaptic membranes and on non-noradrenergic nerve terminals of the rat brain cortex.

Authors:  K Fink; M Blohm; G Molderings; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.